BeyondSpring (NASDAQ:BYSI) Shares Down 6.6%

Shares of BeyondSpring Inc. (NASDAQ:BYSI) dropped 6.6% during trading on Thursday . The stock traded as low as $2.26 and last traded at $2.27. Approximately 28,389 shares traded hands during mid-day trading, a decline of 85% from the average daily volume of 185,227 shares. The stock had previously closed at $2.43.

BeyondSpring Stock Down 6.2 %

The company has a fifty day simple moving average of $2.42 and a two-hundred day simple moving average of $1.47.

Institutional Investors Weigh In On BeyondSpring

Several hedge funds have recently modified their holdings of BYSI. Decheng Capital Management III Cayman LLC acquired a new position in shares of BeyondSpring in the 3rd quarter valued at about $3,967,000. Capstone Capital Wealth Advisors acquired a new position in BeyondSpring during the fourth quarter valued at approximately $45,000. Finally, Decheng Capital LLC purchased a new stake in BeyondSpring during the fourth quarter worth approximately $4,450,000. 40.29% of the stock is owned by institutional investors and hedge funds.

BeyondSpring Company Profile

BeyondSpring Inc, a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and for treatment of later-stage non-small cell lung cancer.